Passage Bio, Inc.

US$3.98As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PASGHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (50.58%)
Div yield —
ROE (169.09%)
Biotechnology
Beta (5Y) 1.49
PE TTM —
TSR TTM (48.24%)
Mkt cap US$12.79M
ROIC (70.60%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.86
(2.98%)
26.76%
Hold 5|11|1|0|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.09
0.10
0.11
0.11
23.77%
29.08%
39.72%
36.93%
Revenue$M
0.881
0.885
0.932
0.920
4.19%
2.39%
5.99%
7.70%
Peers (US$12.79M)
Cap (US$)
PE
12.87M
—
Capital
TTM
5Y
10Y
Leveragex
1.093
0.430
0.478
EBIT/Intx
1.117
0.252
0.240
Own earn%
415.58
35.79
24.57
Sh yield%
41.31
42.72
43.04
Owners
Insiders/Inst%
0.76
71.88
Short interest%
4.11
SBC / revenue%
3.25
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
26–30
$1 testx
0.0
Incr. ROIC%
17